US International Trade Commission takes on Eli Lilly's tirzepatide case
The US International Trade Commission is opening an investigation into the alleged sale of unapproved versions of Eli Lilly’s weight loss and diabetes drug tirzepatide …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.